- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01093950
White Light Scanning to Aid Body Contouring: A Pilot Project
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: David A Gilbert, MD
- Phone Number: 757-274-4000
- Email: dagilb3@msn.com
Study Contact Backup
- Name: ROBERT H SCHNARRS, MD
- Phone Number: 757-274-4000
- Email: HAGUE400@AOL.COM
Study Locations
-
-
Virginia
-
Norfolk, Virginia, United States, 23510
- Recruiting
- The Hague Center
-
Contact:
- David A Gilbert, MD
- Phone Number: 757-274-4000
- Email: dagilb3@msn.com
-
Principal Investigator:
- David A. Gilbert, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All healthy preoperative body contouring subjects between 18-65 years old are potentially included in this study.
Exclusion Criteria:
- Pregnant, nursing,or have a history of epilepsy.
- Individuals under 18 years old;
- Problems reading or understanding spoken instructions;
- Are in jail or in a "locked ward";
- Are a student or an employee of EVMS; or
- Are chemically-dependent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
PROSPECTIVE BODY CONTOURING SUBJECTS
It is anticipated that the participants will undergo body contouring procedures including lipoplasty [internal fat suction removal], abdominoplasty [surgical removal of lower abdominal skin and fat], breast reduction [surgical removal of breast skin, fat, and breast tissue to reduce breast size], breast augmentation [surgical breast enlargement], thigh lift [surgical removal of upper thigh tissue], and brachioplasty [surgical removal of upper arm tissue]. These procedures will be evaluated by pre- and post-operative digital scans, analog measurements, and clinical examinations and photographs. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To study whether the scanner was faster and more accurate than anthropometric measurements.
Time Frame: 9 months
|
The scanner and anthropometric measurements will be compared for accuracy and fidelity of collection.
Anthropometric tape measurements will be compared to measurement extraction profiles provided by the scanner.Conclusions will be drawn based on the data collected.
|
9 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: David A Gilbert, MD, Eastern Virginia Medical School
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05-09-FB-0235
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lipodystrophy
-
University Hospital, LilleRecruitingFamilial Partial Lipodystrophy Type 2France
-
Aegerion Pharmaceuticals, Inc.RecruitingPartial Lipodystrophy | Generalised LipodystrophyUnited States, Germany, Italy
-
Amryt PharmaRecruitingPartial LipodystrophyUnited States, Canada
-
Regeneron PharmaceuticalsAvailablePartial Lipodystrophy | Generalized Lipodystrophy | Monogenic Obesity Due to LEP or LEPR Loss of Function
-
University of UlmUniversity of Pisa; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Medical... and other collaboratorsRecruitingLipodystrophy Acquired | Lipodystrophy CongenitalAustria, France, Germany, Hungary, Italy, Portugal, Spain, Netherlands, Russian Federation, Slovenia, Switzerland, Turkey, United Kingdom
-
University of Texas Southwestern Medical CenterCompletedInsulin Resistance | Partial Lipodystrophy | Generalized Lipodystrophy | HypoleptinemiaUnited States
-
Regeneron PharmaceuticalsActive, not recruitingGeneralized LipodystrophyUnited States, Peru, Russian Federation, Turkey
-
Mayo ClinicCompleted
-
Escola Superior de Tecnologia da Saúde do PortoCompleted
-
University of Texas Southwestern Medical CenterTerminated